Thu.Jan 19, 2023

article thumbnail

ICYMI: PhRMA kicks off the year at the 2023 J.P. Morgan Health Care Conference

PhRMA

This January, PhRMA joined health care leaders, investors, R&D experts and members of the media at the 2023 J.P. Morgan Health Care Conference in San Francisco, CA. During this week, we discussed ways to improve patient outcomes, access and affordability in our health care system.

197
197
article thumbnail

SmartRx Joins Other Prescription Drug Discount Programs

Drug Topics

A new membership program, SmartRx, offers consumers savings on prescriptions, as well as office visits, eye care, vaccines and pet meds.

Vaccines 187
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study: Empagliflozin Can Slow Progression of Chronic Kidney Disease to Kidney Failure

Pharmacy Times

Data from a randomized clinical trial supports previous clinical findings on SGLT2 inhibitors and their ability to slow the progression of chronic kidney disease.

158
158
article thumbnail

A new study links social media use to changes in teen brains. Is that a bad thing?

STAT

Today’s teens and tweens have never known a world without social media. There are still a lot of open questions about how sites like TikTok and Instagram may shape their development — and stories focusing on the potential negative impacts of social media tend to dominate the news. But a recent study published in JAMA Pediatrics is the latest in a growing body of research that suggests the relationship that young people have with social media is too complicated to be categorized as

133
133
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

ADHD Traits Linked to Anxiety, Depression More Than Autistic Traits

Pharmacy Times

There is a lack of funding for attention-deficit hyperactivity disorder and coinciding psychological research compared to the funds generated for autism research.

148
148
article thumbnail

Extended-Release Risperidone Approved by FDA for Schizophrenia

Drug Topics

Rykindo is a bi-weekly long-acting risperidone injection to treat patients with schizophrenia and bipolar 1 in adults.

FDA 144

More Trending

article thumbnail

Vitamin C Supplements for Pregnant Patients Can Improve Airway Function in Children

Drug Topics

A follow-up of a trial cohort showed that children aged 5 years born to pregnant smokers had improved airway function when vitamin C supplementation was administered during pregnancy compared to placebo.

98
article thumbnail

Let’s Get Social: The Ascendancy of Social Media to the Top of the Media Mix

PharmExec

Fran Pollaro talks with Amanda Powers-Han, chief marketing officer at Greater Than One, a full-experience marketing agency dedicated to healthcare, about what’s trending in early 2023 for pharma media mixes.

111
111
article thumbnail

How Opioid Use Disorder Can Impact Contraceptive Use

Drug Topics

Women on Medicaid with opioid use disorder (OUD) who use medications for opioid use disorder (MOUD) are more likely to use contraception and to undergo female sterilization than peers not prescribed MOUD.

98
article thumbnail

Study: Racial, Ethnic Minority Groups More Likely to Have Delayed Cancer Treatment After COVID-19 Infection

Pharmacy Times

Older patients received cancer treatment less frequently during the pandemic, as did patients covered by Medicaid.

132
132
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

UnitedHealthcare launches behavioral health coaching program for commercial plans

Fierce Healthcare

UnitedHealthcare launches behavioral health coaching program for commercial plans pminemyer Thu, 01/19/2023 - 15:05

137
137
article thumbnail

What’s Next in Health Care: How Pharmacies Can Help Serve Their Communities Better

Pharmacy Times

Key trends such as consolidation create an opportunity for independent pharmacies with a community-based approach.

article thumbnail

Vaxxas announces CEPI partnership to advance needle-free mRNA vaccine patches

pharmaphorum

Biotech Vaxxas has announced a partnership agreement with the 2017-established Coalition for Epidemic Preparedness Innovations (CEPI), in order to advance the development of Vaxxas’ needle-free vaccine-patch delivery technology with preclinical testing of an mRNA vaccine patch. CEPI is a partnership between public, private, philanthropic, and civil organisations to develop vaccines against future epidemics and pandemics.

Vaccines 105
article thumbnail

Barriers to Optimal Care for Patients Diagnosed with MDS

Pharmacy Times

Dr Mancini navigates challenges inhibiting patients to receive optimal care amid diagnosis of MDS.

139
139
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Mass Appeal: How marketers are winning the skin care game

Drug Store News

Mass market skin care sales remain a bright spot in the beauty category — outpacing gains in most other categories. DSN is investigating why shoppers think it is cool to buy mass skin care right now.

105
105
article thumbnail

Pharmacies Gear Up for DSCSA Interoperability Go-Live Deadline

Pharmacy Times

November 27, 2023, marks date set by statute for full implementation of Drug Supply Chain Security Act.

132
132
article thumbnail

In a post-Dobbs world, pathologists who study pregnancy loss walk a thin line between medicine and the law

STAT

When Mana Parast examines a placenta, she knows she may never find the answers she seeks. She’s hunting for clues — strips of dead tissue that signal autoimmune disease, white blood cells in the lining of the umbilical cord that point to an infection, thickening that could suggest blood wasn’t flowing freely to the fetus. She wants to be able to tell a parent what she thinks went wrong.

102
102
article thumbnail

Lloyds Pharmacy to close all 237 Sainsbury’s outlets

The Guardian - Pharmaceutical Industry

Group says move due to ‘changing market conditions’ as industry warns of insufficient government funding Lloyds Pharmacy is closing all 237 of its outlets in Sainsbury’s supermarkets amid fears of insufficient government funding for the industry. The group said it was making the closures – which are thought to affect about 2,000 jobs – “in response to changing market conditions”, adding it was “currently exploring options for each individual branch”.

99
article thumbnail

STAT+: For only the second time, a big drugmaker offers a warranty on a medicine

STAT

In a bid to blunt competition and address rising drug costs, Sanofi is offering a warranty that will cover the cost for any hospital if a specific medicine fails to work, marking only the second time a major pharmaceutical company has taken such a step. In this instance, Sanofi designed a warranty program for its Cablivi medication, which is used to treat aTTP, a rare, life-threatening autoimmune blood disorder that is considered a medical emergency.

article thumbnail

Alabama town learns farmer secretly paid people’s pharmacy bills

The Guardian - Pharmaceutical Industry

Hody Childress donated $100 a month for neighbors who couldn’t pay their prescriptions until his recent death A small town in Alabama is honoring a man who paid off his neighbors’ pharmacy bills for years and kept his generosity a secret until shortly before his recent death by picking up exactly where he left off. Hody Childress, a farmer and US air force veteran, began his anonymous charitable campaign when he walked into a drug store in his home town of Geraldine in 2012 and learned from the

99
article thumbnail

‘Hot mess’: Abortion pills at pharmacies could face legal quagmires, especially in restrictive states

STAT

WASHINGTON — Federal regulators’ green light for pharmacists to dispense abortion pills is crashing into legal questions and simmering court battles. The Food and Drug Administration earlier this month removed a longtime restriction that only doctors could dispense mifepristone, which is approved for abortions up to 10 weeks. The move opens the door for pharmacists to supply the drugs and shores up protections for mail orders, which have become an important channel for abortion acc

FDA 102
article thumbnail

US FDA grants Fast Track status for Avidity’s AOC 1020 to treat FSHD

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted Fast Track designation for Avidity Biosciences’ AOC 1020 to treat facioscapulohumeral muscular dystrophy (FSHD). AOC 1020 has been designed for the treatment of the underlying cause of FSHD, which is caused by the abnormal expression of a gene known as double homeobox 4 or DUX4. This DUX4 protein abnormal expression leads to modifications in gene expression in muscle cells which are associated with progressive muscle function loss in FSHD pat

FDA 98
article thumbnail

STAT+: Will the European Union give vouchers to pharma to develop badly needed antibiotics?

STAT

Amid rising concern over antibiotic resistance, a battle is brewing in Europe over a proposal to offer vouchers to companies as an incentive to develop new treatments. The controversial idea has already raised objections from more than a dozen members of the European Union. The basic premise is straightforward. A company that wins regulatory approval for a novel antibiotic gets a voucher that can then be used to extend for one year the exclusive rights to the results of clinical trial data for a

article thumbnail

Does Zoloft cause weight gain?

The Checkup by Singlecare

Zoloft ( sertraline ) is a prescription medication that belongs to the selective serotonin reuptake inhibitor ( SSRI ) class of antidepressants. Zoloft is often prescribed as part of a treatment plan, which may include other methods such as cognitive behavioral therapy, to treat major depressive disorder ( depression ) or other mental health conditions, including: Obsessive-compulsive disorder (OCD) Panic disorder (PD) Post-traumatic stress disorder (PTSD) Social anxiety disorder (SAD) Premenstr

98
article thumbnail

Opinion: Upcoding: one reason Medicare Advantage companies pay clinicians to make home health checkups

STAT

At the start of 2023, an estimated 2.5 million Americans age 65 and older began using Medicare Advantage programs. Some made this choice in response to aggressive marketing campaigns. This brings the total enrollment of Medicare Advantage plans to nearly 31 million. One unexpected “benefit” of these plans is an offer by the insurance company sponsoring the plan to send a nurse or physician’s assistant, often from a startup company, to an individual’s home.

Insurance 100
article thumbnail

Publix opens 4th telehealth site with Beaufort Memorial Hospital

Drug Store News

The telehealth centers include a private room with teleconferencing and medical diagnostic equipment like stethoscopes, blood pressure cuffs, high-definition cameras and other tools necessary for common diagnoses.

article thumbnail

With Gates Foundation backing, a health tech company aims to speed diagnosis of some neglected tropical diseases

STAT

As it looks to curb the spread of infectious diseases, the Gates Foundation is lending its support to an effort to use artificial intelligence to make it easier for health providers in India and Nigeria to quickly diagnose certain conditions. The funding will support New York-based clinical decision support company VisualDx, which began as a collection of images to allow non-dermatologists to better identify skin conditions.

100
100
article thumbnail

Dollar General to offer cash back rewards via Ibotta partnership

Drug Store News

Consumers can receive cash back rewards on thousands of items at Dollar General through Ibotta’s platform and expect cash back rewards available directly through Dollar General’s app and website.

98
article thumbnail

Listen: How blockbusters get made, new vaccines for RSV, and mRNA’s Q score

STAT

Where do new drugs come from? Does science need billionaires? And do normal people care about messenger RNA? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Journalist Nathan Vardi joins us to talk about his new book delving into the race to develop the lifesaving cancer drug now called Imbruvica, involving a Scientologist CEO and secretive investor seeking redemption after the worst trade of his life.

Vaccines 104
article thumbnail

Pharmacy united in the recovery of healthcare

Hospital Pharmacy Europe

Pharmacists from around the world gathered in Seville for the 80th FIP World Congress of Pharmacy and Pharmaceutical Sciences. Key topics included antimicrobial stewardship, mental health challenges and health literacy FIP has had a long-standing commitment to combatting antimicrobial resistance (AMR) and antimicrobial stewardship (AMS) is one of the organisation’s key development goals.

article thumbnail

Opinion: Medical school rankings need a new metric: economic mobility index

STAT

What are the attributes of a great medical school? U.S. News & World Report’s ranking system says the best American medical schools score high in areas that include the quality of the school’s curriculum (based on the opinions of deans, school administrators, and hospital residency directors); grade-point averages and standardized test scores of incoming students; student-to-faculty ratios; federal research activity; and the proportion of graduates who specialize in primary car

article thumbnail

Sun Pharma agrees deal to buy alopecia player Concert

pharmaphorum

India’s Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of hair loss. The $11.50 per share deal includes $8 per share upfront, worth around $576 million, with the remainder in the form of a contingent value right (CVR) that will be paid to Concert shareholders if deuroxilitinib meets certain sales targets within a set time limit.

article thumbnail

STAT+: FDA rejects Lilly’s bid for accelerated approval for its Alzheimer’s drug

STAT

Eli Lilly said Thursday that U.S. regulators had rejected its application seeking accelerated approval for donanemab, a treatment for people with early stage Alzheimer’s disease. Despite the setback, Lilly said that the planned readout from an ongoing, Phase 3 study of donanemab remains on track for the middle of the year, and if positive, will form the basis of an application for full approval “shortly thereafter.

FDA 98
article thumbnail

JP Morgan 2023 – Raj Chopra

pharmaphorum

On the sidelines of JP Morgan 2023, pharmaphorum editor-in-chief Jonah Comstock sat down with Raj Chopra, acting CEO of Aethon Therapeutics. Aethon recently launched January 9th, with $30 million in funding as a collaboration between Apple Tree Partners and NYU Langone Health. In this interview, Chopra describes the HapImmune technology behind the company, which uses customised antibodies to create covalent inhibitors that bind to target proteins to create a peptide conjugate “beacon” that only

97